IRF7 and systemic sclerosis: Experimental evidence demonstrated that interferon regulatory factor 7 (IRF7), a pivotal regulator of type I interferon signaling, was upregulated in SSc skin, interacted with Smad3, and enhanced TGF-β-mediated fibrosis (72).